国际内分泌代谢杂志
國際內分泌代謝雜誌
국제내분비대사잡지
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM
2014年
6期
418-421
,共4页
刘春梅%周涛%吴鹏%孙强%郭亚南
劉春梅%週濤%吳鵬%孫彊%郭亞南
류춘매%주도%오붕%손강%곽아남
脉管复康片%内皮细胞功能%糖尿病下肢动脉闭塞症
脈管複康片%內皮細胞功能%糖尿病下肢動脈閉塞癥
맥관복강편%내피세포공능%당뇨병하지동맥폐새증
Maiguan Fukang tablets%Endothelial cell function%Diabetic arterial occlusion of lower extremities
目的 观察糖尿病下肢动脉闭塞症(DAO)患者血管内皮细胞功能的变化及脉管复康片干预的作用机制.方法 66例DAO患者按随机表法分为治疗组与对照组,每组33例,分别服用脉管复康片4片/次,3次/d;或通塞脉片4片/次,3次/d,疗程均为8周.观察两组患者治疗后临床症状、体征、光电血流描记、踝/肱比指数以及血液流变学、内皮细胞因子等指标.结果 治疗组在改善临床症状方面优于对照组(P<0.05);治疗后两组血黏度、纤维蛋白原均有降低,治疗组比对照组更为显著(P<0.01);治疗后在血浆一氧化氮、内皮素-1水平变化方面,治疗组效果优于对照组,有显著性差异(P<0.01).结论 脉管复康片可改善DAO患者临床症状,主要是通过调节血管内皮细胞功能,降低血黏度发挥作用.
目的 觀察糖尿病下肢動脈閉塞癥(DAO)患者血管內皮細胞功能的變化及脈管複康片榦預的作用機製.方法 66例DAO患者按隨機錶法分為治療組與對照組,每組33例,分彆服用脈管複康片4片/次,3次/d;或通塞脈片4片/次,3次/d,療程均為8週.觀察兩組患者治療後臨床癥狀、體徵、光電血流描記、踝/肱比指數以及血液流變學、內皮細胞因子等指標.結果 治療組在改善臨床癥狀方麵優于對照組(P<0.05);治療後兩組血黏度、纖維蛋白原均有降低,治療組比對照組更為顯著(P<0.01);治療後在血漿一氧化氮、內皮素-1水平變化方麵,治療組效果優于對照組,有顯著性差異(P<0.01).結論 脈管複康片可改善DAO患者臨床癥狀,主要是通過調節血管內皮細胞功能,降低血黏度髮揮作用.
목적 관찰당뇨병하지동맥폐새증(DAO)환자혈관내피세포공능적변화급맥관복강편간예적작용궤제.방법 66례DAO환자안수궤표법분위치료조여대조조,매조33례,분별복용맥관복강편4편/차,3차/d;혹통새맥편4편/차,3차/d,료정균위8주.관찰량조환자치료후림상증상、체정、광전혈류묘기、과/굉비지수이급혈액류변학、내피세포인자등지표.결과 치료조재개선림상증상방면우우대조조(P<0.05);치료후량조혈점도、섬유단백원균유강저,치료조비대조조경위현저(P<0.01);치료후재혈장일양화담、내피소-1수평변화방면,치료조효과우우대조조,유현저성차이(P<0.01).결론 맥관복강편가개선DAO환자림상증상,주요시통과조절혈관내피세포공능,강저혈점도발휘작용.
Objective To investigate the effects and mechanisms of Maiguan Fukang tablets on the function of vascular endothelial cells in patients with diabetic arterial occlusion of lower extremities (DAO).Methods Sixty-six patients with DAO were divided into treatment group and control group by random table method,with 33 patients in each group.Four pieces of Maiguan Fukang tablets or Tongsaimai tablets three times a day were prescribed to the patients for 8 weeks.The clinical symptoms and signs,photoelectric flow tracings,ankle brachial index,heamorheology,markers of endothelial cell function were assessed after treatment.Results Clinical symptoms were improved in treatment group compared with control group (P < 0.05).Blood viscosity and fibrinogen level were reduced in both groups,but were more evident in treatment group (P < 0.01).Plasma nitric oxide and endothelin-1 level in treatment group were also improved significantly compared with those in control group (P < 0.01).Conclusion Maiguan Fukang tablets can improve the clinical symptoms for patients with DAO,which may act through regulating vascular endothelial function and decreasing blood viscosity.